{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:13:59Z","timestamp":1787026439337,"version":"build-2736575974"},"reference-count":79,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,10,3]],"date-time":"2023-10-03T00:00:00Z","timestamp":1696291200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Obesity poses an increased risk for the onset of Nonalcoholic fatty liver disease (NAFLD). The influence of other factors, such as sex in the incidence and severity of this liver disease has not yet been fully elucidated. Thus, we aimed to identify the NAFLD serum metabolic signatures associated with sex in normal, overweight and obese patients and to associate the metabolite fluctuations across the increasing liver steatosis stages.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and results<\/jats:title>\n                    <jats:p>Using nuclear magnetic resonance (NMR) serum samples of 210 NAFLD cases and control individuals diagnosed with liver U\/S, our untargeted metabolomics enquiry provided a sex distinct metabolic bouquet. Increased levels of alanine, histidine and tyrosine are associated with severity of NAFLD in both men and women. Moreover, higher serum concentrations of valine, aspartic acid and mannose were positively associated with the progression of NAFLD among the male subjects, while a negative association was observed with the levels of creatine, phosphorylcholine and acetic acid. On the other hand, glucose was positively associated with the progression of NAFLD among the female subjects, while levels of threonine were negatively related. Fluctuations in ketone bodies acetoacetate and acetone were also observed among the female subjects probing a significant reduction in the circulatory levels of the former in NAFLD cases. A complex glycine response to hepatic steatosis of the female subjects deserves further investigation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Results of this study aspire to address the paucity of data on sex differences regarding NAFLD pathogenesis. Targeted circulatory metabolome measurements could be used as diagnostic markers for the distinct stages of NAFLD in each sex and eventually aid in the development of novel sex-related therapeutic options.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fendo.2023.1230457","type":"journal-article","created":{"date-parts":[[2023,10,5]],"date-time":"2023-10-05T09:34:47Z","timestamp":1696498487000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":23,"title":["Serum metabolomic profiling unveils distinct sex-related metabolic patterns in NAFLD"],"prefix":"10.3389","volume":"14","author":[{"given":"Charalambos","family":"Fotakis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioanna-Panagiota","family":"Kalafati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athina I.","family":"Amanatidou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasiliki","family":"Andreou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manolis","family":"Matzapetakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Kafyra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iraklis","family":"Varlamis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Zervou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George V.","family":"Dedoussis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,10,3]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.25762","article-title":"The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association","volume":"55","author":"Chalasani","year":"2012","journal-title":"Hepatology"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1111\/cts.12839","article-title":"Evolving role for pharmacotherapy in NAFLD\/NASH","volume":"14","author":"Attia","year":"2021","journal-title":"Clin Trans Sci"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1002\/hep.29367","article-title":"The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases","volume":"67","author":"Chalasani","year":"2018","journal-title":"Hepatology"},{"key":"B4","doi-asserted-by":"publisher","first-page":"830","DOI":"10.3390\/jpm13050830","article-title":"Precision medicine in fatty liver disease\/non-alcoholic fatty liver disease","volume":"13","author":"Valenzuela-Vallejo","year":"2023","journal-title":"J Pers Med"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1111\/liv.14943","article-title":"Clinical impact of sexual dimorphism in non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH)","volume":"41","author":"Burra","year":"2021","journal-title":"Liver international: Off J Int Assoc Study Liver"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1002\/hep.30626","article-title":"Sex differences in nonalcoholic fatty liver disease: state of the art and identification of research gaps","volume":"70","author":"Lonardo","year":"2019","journal-title":"Hepatology"},{"key":"B7","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1038\/s41467-023-36231-7","article-title":"Atlas of plasma NMR biomarkers for health and disease in 118,461 individuals from the UK Biobank","volume":"14","author":"Julkunen","year":"2023","journal-title":"Nat Commun"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-021-00502-9","article-title":"Metabolomics and lipidomics in NAFLD: biomarkers and non-invasive diagnostic tests","volume":"18","author":"Masoodi","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3350\/cmh.2021.0127","article-title":"Recent advances in nonalcoholic fatty liver disease metabolomics","volume":"27","author":"Kim","year":"2021","journal-title":"Clin Mol Hepatol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3390\/metabo8010017","article-title":"Study of the serum metabolomic profile in nonalcoholic fatty liver disease: research and clinical perspectives","volume":"8","author":"Gitto","year":"2018","journal-title":"Metabolites"},{"key":"B11","doi-asserted-by":"publisher","first-page":"694","DOI":"10.3390\/metabo11100694","article-title":"Contribution of metabolomics to the understanding of NAFLD and NASH syndromes: A systematic review","volume":"11","author":"Piras","year":"2021","journal-title":"Metabolites"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.nut.2018.10.032","article-title":"Dietary patterns and non-alcoholic fatty liver disease in a Greek case-control study","volume":"61","author":"Kalafati","year":"2019","journal-title":"Nutrition"},{"key":"B13","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","article-title":"Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge","volume":"18","author":"Friedewald","year":"1972","journal-title":"Clin Chem"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"key":"B15","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/1471-230X-6-33","article-title":"The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population","volume":"6","author":"Bedogni","year":"2006","journal-title":"BMC Gastroenterol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1021\/ac503651e","article-title":"Expanding the limits of human blood metabolite quantitation using NMR spectroscopy","volume":"87","author":"Nagana Gowda","year":"2015","journal-title":"Anal Chem"},{"key":"B17","doi-asserted-by":"publisher","first-page":"4248","DOI":"10.3390\/ijms23084248","article-title":"Uncontrolled thyroid during pregnancy alters the circulative and exerted metabolome","volume":"23","author":"Fotakis","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B18","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1007\/s11306-017-1286-8","article-title":"Automated metabolite identification from biological fluid 1H NMR spectra","volume":"13","author":"Filntisi","year":"2017","journal-title":"Metabolomics"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1002\/cem.695","article-title":"Orthogonal projections to latent structures (O-PLS)","volume":"16","author":"Trygg","year":"2002","journal-title":"J Chemom"},{"key":"B20","first-page":"1","volume-title":"Multi- and Megavariate Data Analysis. Part I Basic Principles and Applications. Second revised and enlarged edition","author":"Eriksson","year":"2006"},{"key":"B21","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1002\/cem.1187","article-title":"CV-ANOVA for significance testing of PLS and OPLS\u00ae models","volume":"22","author":"Eriksson","year":"2008","journal-title":"J Chemom"},{"key":"B22","doi-asserted-by":"publisher","first-page":"e00112","DOI":"10.1002\/edm2.112","article-title":"The metabolic basis of nonalcoholic steatohepatitis","volume":"3","author":"Chakravarthy","year":"2020","journal-title":"Endocrinol Diabetes Metab"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1038\/s41574-021-00538-6","article-title":"Hepatic sexual dimorphism \u2014 implications for non-alcoholic fatty liver disease","volume":"17","author":"Lefebvre","year":"2021","journal-title":"Nat Rev Endocrinol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.3390\/jcm9051278","article-title":"Sexual dimorphism of NAFLD in adults. Focus on clinical aspects and implications for practice and translational research","volume":"9","author":"Lonardo","year":"2020","journal-title":"J Clin Med"},{"key":"B25","doi-asserted-by":"publisher","first-page":"2502","DOI":"10.3390\/cells10092502","article-title":"Beyond the X factor: relevance of sex hormones in NAFLD pathophysiology","volume":"10","author":"Della Torre","year":"2021","journal-title":"Cells"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)31561-0","article-title":"Sex and gender: modifiers of health, disease, and medicine","volume":"396","author":"Mauvais-Jarvis","year":"2020","journal-title":"Lancet"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-70178-3_12","article-title":"Role of estrogens in the regulation of liver lipid metabolism","volume":"1043","author":"Palmisano","year":"2017","journal-title":"Adv Exp Med Biol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/s41574-020-00431-8","article-title":"Sexual dimorphism in cardiometabolic health: the role of adipose tissue, muscle and liver","volume":"17","author":"Goossens","year":"2021","journal-title":"Nat Rev Endocrinol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1093\/eurjpc\/zwac060","article-title":"Menopause modulates the circulating metabolome: evidence from a prospective cohort study","volume":"29","author":"Karppinen","year":"2022","journal-title":"Eur J Prev Cardiol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1002\/hep.29465","article-title":"Altered amino acid concentrations in NAFLD: Impact of obesity and insulin resistance","volume":"67","author":"Gaggini","year":"2018","journal-title":"Hepatology"},{"key":"B31","doi-asserted-by":"publisher","first-page":"29","DOI":"10.2147\/HMER.S79100","article-title":"Tyrosine levels are associated with insulin resistance in patients with nonalcoholic fatty liver disease","volume":"7","author":"Kawanaka","year":"2015","journal-title":"Hepatic medicine: evidence Res"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1172\/JCI131931","article-title":"Hungry for your alanine: when liver depends on muscle proteolysis","volume":"129","author":"Sarabhai","year":"2019","journal-title":"J Clin Invest"},{"key":"B33","doi-asserted-by":"publisher","first-page":"101080","DOI":"10.1016\/j.molmet.2020.101080","article-title":"Glucagon acutely regulates hepatic amino acid catabolism and the effect may be disturbed by steatosis","volume":"42","author":"Winther-S\u00f8rensen","year":"2020","journal-title":"Mol Metab"},{"key":"B34","doi-asserted-by":"publisher","first-page":"14485","DOI":"10.1038\/s41598-017-14974-w","article-title":"Plasma amino acid profile associated with fatty liver disease and co-occurrence of metabolic risk factors","volume":"7","author":"Yamakado","year":"2017","journal-title":"Sci Rep"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.3177\/jnsv.66.561","article-title":"Gene expression and histochemical analyses in the fatty livers of rats fed a histidine-excess diet","volume":"66","author":"Fujimi","year":"2020","journal-title":"J Nutr Sci Vitaminol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.3390\/biomedicines10061444","article-title":"The emerging role of branched-chain amino acids in liver diseases","volume":"10","author":"Lo","year":"2022","journal-title":"Biomedicines"},{"key":"B37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1210\/clinem\/dgaa175","article-title":"Plasma BCAA changes in patients with NAFLD are sex dependent","volume":"105","author":"Grzych","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"B38","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.molmet.2019.12.009","article-title":"Hepatic ER\u03b1 accounts for sex differences in the ability to cope with an excess of dietary lipids","volume":"32","author":"Meda","year":"2020","journal-title":"Mol Metab"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-017-4325-0","article-title":"Early metabolic markers identify potential targets for the prevention of type 2 diabetes","volume":"60","author":"Peddinti","year":"2017","journal-title":"Diabetologia"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinre.2019.01.001","article-title":"Non-alcoholic fatty liver disease causes dissociated changes in metabolic liver functions","volume":"43","author":"Lykke Eriksen","year":"2019","journal-title":"Clinics Res Hepatol Gastroenterol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"100780","DOI":"10.1016\/j.jhepr.2023.100780","article-title":"Role of ammonia in NAFLD: an unusual suspect","volume":"5","author":"Thomsen","year":"2023","journal-title":"JHEP Rep"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1007\/s00726-016-2183-6","article-title":"Creatine supplementation as a possible new therapeutic approach for fatty liver disease: early findings","volume":"48","author":"Deminice","year":"2016","journal-title":"Amino Acids"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/j.jceh.2019.06.004","article-title":"Peroxisome proliferator-activated receptors and their agonists in nonalcoholic fatty liver disease","volume":"9","author":"Choudhary","year":"2019","journal-title":"J Clin Exp Hepatol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamem.2017.04.006","article-title":"The critical role of phosphatidylcholine and phosphatidylethanolamine metabolism in health and disease","volume":"1859","author":"van der Veen","year":"2017","journal-title":"Biochim Biophys Acta Biomembranes"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1111\/liv.14174","article-title":"Total liver phosphatidylcholine content associates with non-alcoholic steatohepatitis and glycine N-methyltransferase expression","volume":"39","author":"Mannisto","year":"2019","journal-title":"Liver international: Off J Int Assoc Study Liver"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1002\/hep.21763","article-title":"A lipidomic analysis of nonalcoholic fatty liver disease","volume":"46","author":"Puri","year":"2007","journal-title":"Hepatology"},{"key":"B47","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1186\/s40168-021-01125-7","article-title":"Commensal microbe-derived acetate suppresses NAFLD\/NASH development via hepatic FFAR2 signalling in mice","volume":"9","author":"Aoki","year":"2021","journal-title":"Microbiome"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2020.567654","article-title":"Microbial metabolites: critical regulators in NAFLD","volume":"11","author":"Dai","year":"2020","journal-title":"Front Microbiol"},{"key":"B49","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.pharmthera.2017.07.008","article-title":"Stable isotope-based flux studies in nonalcoholic fatty liver disease","volume":"181","author":"McCullough","year":"2018","journal-title":"Pharmacol Ther"},{"key":"B50","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.3390\/nu11061356","article-title":"Glycine metabolism and its alterations in obesity and metabolic diseases","volume":"11","author":"Alves","year":"2019","journal-title":"Nutrients"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aaz2841","article-title":"Glycine-based treatment ameliorates NAFLD by modulating fatty acid oxidation, glutathione synthesis, and the gut microbiome","volume":"12","author":"Rom","year":"2020","journal-title":"Sci Trans Med"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1172\/JCI76388","article-title":"Ketogenesis prevents diet-induced fatty liver injury and hyperglycemia","volume":"124","author":"Cotter","year":"2014","journal-title":"J Clin Invest"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2022.946474","article-title":"Emerging role of hepatic ketogenesis in fatty liver disease","volume":"13","author":"Mooli","year":"2022","journal-title":"Front Physiol"},{"key":"B54","doi-asserted-by":"publisher","first-page":"e13627","DOI":"10.1111\/eci.13627","article-title":"Nonalcoholic fatty liver disease, circulating ketone bodies and all-cause mortality in a general population-based cohort","volume":"51","author":"Post","year":"2021","journal-title":"Eur J Clin Invest"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.127737","article-title":"Impaired ketogenesis and increased acetyl-CoA oxidation promote hyperglycemia in human fatty liver","volume":"5","author":"Fletcher","year":"2019","journal-title":"JCI Insight"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2021.710420","article-title":"Metabolic changes of hepatocytes in NAFLD","volume":"12","author":"Lu","year":"2021","journal-title":"Front Physiol"},{"key":"B57","doi-asserted-by":"publisher","first-page":"612089","DOI":"10.1155\/2010\/612089","article-title":"Peroxisome proliferator-activated receptor alpha target genes","volume":"2010","author":"Rakhshandehroo","year":"2010","journal-title":"PPAR Res"},{"key":"B58","doi-asserted-by":"publisher","first-page":"42477","DOI":"10.1038\/srep42477","article-title":"Pemafibrate, a novel selective peroxisome proliferator-activated receptor alpha modulator, improves the pathogenesis in a rodent model of nonalcoholic steatohepatitis","volume":"7","author":"Honda","year":"2017","journal-title":"Sci Rep"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1039\/D2FO01201D","article-title":"Threonine supplementation prevents the development of fat deposition in mice fed a high-fat diet","volume":"13","author":"Chen","year":"2022","journal-title":"Food Funct"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.26599\/FSHW.2022.9250016","article-title":"Higher intakes of lysine, threonine and valine are inversely associated with non-alcoholic fatty liver disease risk: a community-based case-control study in the Chinese elderly","volume":"13","author":"Li","year":"2024","journal-title":"Food Sci Hum Wellness"},{"key":"B61","doi-asserted-by":"publisher","first-page":"100320","DOI":"10.1016\/j.aohep.2021.100320","article-title":"Hepatic steatosis and respiratory diseases: a new panorama","volume":"24","author":"Botello-Manilla","year":"2021","journal-title":"Ann Hepatol"},{"key":"B62","doi-asserted-by":"publisher","first-page":"e17098","DOI":"10.1097\/MD.0000000000017098","article-title":"Obesity and nonalcoholic fatty liver disease associated with adenocarcinoma in patients with lung cancer","volume":"98","author":"Zhu","year":"2019","journal-title":"Medicine"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2020.05.009","article-title":"Associations between nonalcoholic fatty liver disease and cancers in a large cohort in China","volume":"19","author":"Wang","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2022.1042442","article-title":"Non-alcoholic fatty liver disease (NAFLD) and mental illness: Mechanisms linking mood, metabolism and medicines","volume":"16","author":"Gangopadhyay","year":"2022","journal-title":"Front Neurosci"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1007\/s12072-020-10132-z","article-title":"Prevalence of nonalcoholic fatty liver disease in mental disorder inpatients in China: an observational study","volume":"15","author":"Ma","year":"2021","journal-title":"Hepatol Int"},{"key":"B66","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1186\/s12916-020-01713-8","article-title":"Non-alcoholic fatty liver disease (NAFLD) as a neglected metabolic companion of psychiatric disorders: common pathways and future approaches","volume":"18","author":"Soto-Angona","year":"2020","journal-title":"BMC Med"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2022.07.007","article-title":"Prevalence of metabolic syndrome and related factors in a large sample of antipsychotic naive patients with first-episode psychosis: Baseline results from the PAFIP cohort","volume":"246","author":"Garrido-Torres","year":"2022","journal-title":"Schizophr Res"},{"key":"B68","doi-asserted-by":"publisher","first-page":"114387","DOI":"10.1016\/j.ab.2021.114387","article-title":"Cerebrovascular alterations in NAFLD: Is it increasing our risk of Alzheimer\u2019s disease","volume":"636","author":"Hadjihambi","year":"2022","journal-title":"Anal Biochem"},{"key":"B69","doi-asserted-by":"publisher","first-page":"673","DOI":"10.3390\/jcm10040673","article-title":"Cognitive dysfunction in non-alcoholic fatty liver disease\u2014Current knowledge, mechanisms and perspectives","volume":"10","author":"Kj\u00e6rgaard","year":"2021","journal-title":"J Clin Med"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000200853","article-title":"Nonalcoholic fatty liver disease and risk of dementia: A population-based cohort study","volume":"99","author":"Shang","year":"2022","journal-title":"Neurology"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines9121915","article-title":"Metabolic fatty liver disease in children: A growing public health problem","volume":"9","author":"Le Garf","year":"2021","journal-title":"Biomedicines"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1016\/S1665-2681(19)30890-7","article-title":"Tyrosinemia type I: clinical and biochemical analysis of patients in Mexico","volume":"13","author":"Fernandez-Lainez","year":"2014","journal-title":"Ann Hepatol"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1007\/8904_2015_456","article-title":"PNPO deficiency and cirrhosis: expanding the clinical phenotype","volume":"25","author":"Coman","year":"2016","journal-title":"JIMD Rep"},{"key":"B74","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1111\/cge.13843","article-title":"Phenotypic and molecular spectrum of pyridoxamine-5\u2019-phosphate oxidase deficiency: A scoping review of 87 cases of pyridoxamine-5\u2019-phosphate oxidase deficiency","volume":"99","author":"Alghamdi","year":"2021","journal-title":"Clin Genet"},{"key":"B75","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/8904_2014_338","article-title":"Cirrhosis associated with pyridoxal 5\u2019-phosphate treatment of pyridoxamine 5\u2019-phosphate oxidase deficiency","volume":"17","author":"Sudarsanam","year":"2014","journal-title":"JIMD Rep"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-021-01690-1","article-title":"Perspectives on precision medicine approaches to NAFLD diagnosis and management","volume":"38","author":"Lonardo","year":"2021","journal-title":"Adv Ther"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.3350\/cmh.2020.0136","article-title":"Precision medicine in nonalcoholic fatty liver disease: New therapeutic insights from genetics and systems biology","volume":"26","author":"Sookoian","year":"2020","journal-title":"Clin Mol Hepatol"},{"key":"B78","doi-asserted-by":"publisher","first-page":"100835","DOI":"10.1016\/j.jhepr.2023.100835","article-title":"Non-alcoholic fatty liver disease in Women \u2013 Current Knowledge and Emerging Concepts","author":"Eng","year":"2023","journal-title":"JHEP Rep"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgac068","article-title":"Long or irregular menstrual cycles and risk of prevalent and incident nonalcoholic fatty liver disease","volume":"107","author":"Cho","year":"2022","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2023.1230457\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,5]],"date-time":"2023-10-05T09:34:52Z","timestamp":1696498492000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2023.1230457\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,3]]},"references-count":79,"alternative-id":["10.3389\/fendo.2023.1230457"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2023.1230457","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,3]]},"article-number":"1230457"}}